BrainStorm Details Phase 3 Trial Design of NurOwn for Rapidly Progressing ALS
BrainStorm Cell Therapeutics is sharing the details of the design of its Phase 3 clinical trial evaluating NurOwn as a treatment for people with rapidly progressing amyotrophic lateral sclerosis (ALS), showing that the trial is…